Adagio Medical Holdings, Inc. Renames

TL;DR

Aja Holdco is now Adagio Medical Holdings, Inc. as of Jan 4, 2024.

AI Summary

Adagio Medical Holdings, Inc. filed an 8-K on August 19, 2024, to report a change in its corporate name from Aja Holdco, Inc. to Adagio Medical Holdings, Inc., effective January 4, 2024. The company is incorporated in Delaware and operates in the surgical and medical instruments sector.

Why It Matters

This filing indicates a significant rebranding or restructuring for Adagio Medical Holdings, Inc., which could signal a new strategic direction or market focus.

Risk Assessment

Risk Level: low — The filing is a routine corporate name change and does not involve financial performance or operational changes.

Key Players & Entities

• Adagio Medical Holdings, Inc. (company) — Registrant
• Aja Holdco, Inc. (company) — Former company name
• January 4, 2024 (date) — Effective date of name change
• August 19, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share ADGM The Nasdaq Stock Marke

Filing Documents

• tm2422065d1_8k.htm (8-K) — 31KB
• tm2422065d1_ex99-1.htm (EX-99.1) — 13KB
• 0001104659-24-090842.txt ( ) — 221KB
• adgm-20240819.xsd (EX-101.SCH) — 3KB
• adgm-20240819_lab.xml (EX-101.LAB) — 33KB
• adgm-20240819_pre.xml (EX-101.PRE) — 22KB
• tm2422065d1_8k_htm.xml (XML) — 4KB

01

Item 7.01 Regulation FD Disclosure. On August 19, 2024, Adagio Medical Holdings, Inc., a Delaware corporation (the "Company"), issued a press release announcing certain business updates. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated into this Item 7.01 by reference. The foregoing (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act. Forward-Looking Certain statements in this Current Report on Form 8-K (this " Current Report ") may be considered "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or future financial or operating performance of the Company. For example, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "future," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "propose," "seek," "should," "strive," "will," or "would" or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which may be beyond the control of the Company and could cause actual results to differ materially from those expressed or implied by such forward-looking

forward-looking statements

forward-looking statements.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release dated August 19, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 19, 2024 Adagio Medical Holdings, Inc. By: /s/ John Dahldorf Name: John Dahldorf Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR